What’s been up the past week in terms of news in the stem cell world? The Wall Street Journal reports that the New York Stem Cell Foundation (NYSCF) has signed a 20-year lease on a much larger space, in fact twice the current size, in Manhattan. That would seem to be a great sign of […]
Stem Cell News Briefs: NYSCF, Sleep & Transplants, NFL legends, & More Read More »
NASA researchers have been interested in the effects of space travel and in particular microgravity (μg; not to be confused in this context with the common abbreviation for micrograms) on stem cells. For instance, see the past piece “Stem Cells Take Wild Ride in Space Capsule”. In a new NASA study led by Dr. Eduardo A.C.
Stem cells in space with NASA: microgravity reduces regenerative potential Read More »
It’s been a busy few weeks for the stem cell field. Below are some news briefs on developments. RetractionWatch reports that Piero Anversa is leaving Harvard/Brigham and Women’s Hospital after an investigation and dismissed lawsuit he filed against the institution. All still quiet on the STAP cell front at the same institutions. There’s some more
Stem Cell News Briefs: Anversa, Japan Regs, Ocata Suit, More Read More »
Over the years I’ve heard from quite a few patients of stem cell clinics who feel very strongly about their experiences. Some have quite positive views on getting stem cell interventions, while others feel very negatively about the stem cell clinics. I’ve heard more of the latter kind of experience. People often tell me that
Some patients unhappy with stem cell clinics Read More »
By Heather Main This year I will be attending the World Stem Cell Summit for the first time (see @WSCSummit on Twitter). I was surprised when I looked at the program and recognized so few of the names of speakers; which made me question what this event was about, if not focused on stem cell research.
Good reasons to go to the World Stem Cell Summit Read More »
What’s better for stem cell trials such as for vision loss or Parkinson’s Disease: allogeneic or autologous cells? In a major shift earlier this year, the induced pluripotent stem (IPS) cell trial in Japan for treatment of macular degeneration (MD) switched gears from using the patients’ own cells (called “autologous”) to using banked cells from
Parkinson’s IPS cell trial in Japan switching to allogeneic Read More »
Congratulations to Dr. Jeanne Loring, the winner of the Stem Cell Person of the Year Award for 2015. Facing steep competition from a very tough field of competitors of finalists, Jeanne came out as the winner for her exceptional contributions in 2015 and throughout her many years in the field. She not only has made
Stem Cell Person of the Year 2015: Jeanne Loring Read More »
A patient in Japan has reportedly filed suit against a fat stem cell clinic and has won a judgement of 1.84 million yen in total (about $15,000 USD). The Tokyo District Court reportedly ruled in favor of the patient and most of the award is reimbursement. Authors Ikka, et al report on the case and
Patient Sues Fat Stem Cell Clinic & Wins Read More »
By Heather Main I was a little ashamed of myself that I didn’t know who half of the finalists were in Paul Knoepfler’s Stem Cell Person of the Year Award. I decided to look into it and find out what (or who) I have missed…..Interestingly, 3 of the 7 listed here are not scientists but
Mini-bios on finalists for Stem Cell Person of the Year Read More »
The FDA released more draft guidance with strong relevance to the stem cell field. This October 2015 new draft guidance follows about a year after three other previous draft guidances that made it clear the current FDA thinking on various issues including stromal vascular fraction (SVF; fat stem cells) was much more restrictive than generally
More tough FDA draft guidance on stem cells…still no action Read More »